From: Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study
Total
OS
   Median
> 20 months
   6 month
89.5%
   12 month
83.4%
PFS
Median
(months, 95% CI)
12.1
(8.4-15.8)
80.3%
51.8%